The UCD Gynaecological Oncology Group (UCD-GOG) will deliver a high quality, evidence based, continuously improving, person centred service. This will utilise a comprehensive inter disciplinary approach to achieve best patient outcomes, informed by evidence based clinical care. The UCD-GOG service will be compassionate and caring whilst also being transparent and efficient from point of referral through to survivorship

The UCD Gynaecological Oncology Group (UCD-GOG) incorporating UCD, the Mater Misericordiae University Hospital (MMUH) and St Vincent’s University Hospital is the largest Gynaecological Oncology Group in the country serving over two million people. Our Centre receives referrals from across the country and is one of two Centres nationally accredited to perform exenterative surgery.

In conjunction with our colleagues in the Peritoneal Malignancy Institute at the Mater Hospital, we are the only Centre to offer Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to women with ovarian cancer. In 2020 our Centre was accredited by the European Society of Gynaecological Oncology (ESGO) for advanced ovarian cancer surgery and in July 2021, our Centre was accredited by the ESGO as an Accredited Centre in Gynaeoncology Training.

We offer specialist treatment for all types of gynaecological cancers including advanced surgery, radiotherapy and chemotherapy.

Please see table below for the number of new cancer cases treated at our Centre from 2018 – 2020.

number of new cancer cases treated at our Centre

ESCO Certified CentreESGO Accredited centre logo